Related Experiment Video
Updated: Jun 22, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes
Rozan Abu-Nejem1, Tamara S Hannon1
1Department of Pediatrics, Divisions of Pediatric Endocrinology and Diabetology and Pediatric Health Services Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Youth-onset type 2 diabetes (T2D) is rising globally, causing significant health issues for young people. This condition involves severe insulin resistance and rapid decline in insulin secretion, necessitating new treatment strategies.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pediatric Health
Background:
- Youth-onset type 2 diabetes (T2D) is a growing global health concern.
- This condition poses significant long-term health risks for adolescents and young adults.
- It places a substantial burden on healthcare systems worldwide.
Purpose of the Study:
- To highlight key differences between youth-onset and adult-onset type 2 diabetes.
- To underscore the urgent need for novel therapeutic approaches for T2D in youth.
- To emphasize the requirement for treatments addressing both insulin resistance and pancreatic beta-cell function.
Main Methods:
- Review of current research on youth-onset T2D pathophysiology.
- Comparative analysis of T2D progression in pediatric versus adult populations.
- Examination of existing and potential therapeutic targets for T2D in young individuals.
Main Results:
- Youth-onset T2D exhibits more profound insulin resistance compared to adult-onset T2D.
- Younger individuals experience a faster progression towards the loss of adequate insulin secretion.
- Pancreatic beta-cell failure is a key characteristic of advanced youth-onset T2D.
Conclusions:
- Effective management of youth-onset T2D requires addressing its unique pathophysiological features.
- Therapies must aim to improve insulin sensitivity and preserve insulin secretory capacity throughout life.
- Further research is crucial to develop targeted interventions for this vulnerable population.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

